IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study (NCT03978000)

🧪 Interventions in This Study

• IBP-9414 (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (89 Sites)

Showing the first 25 of 89 sites.

• Banner University Medical Center / University of Arizona — Tucson, Arizona
• Arkansas Children'S Hospital — Little Rock, Arkansas
• University of Arkansas For Medical Services — Little Rock, Arkansas
• Loma Linda University Children Hospital — Loma Linda, California
• Good Samaritan Hospital — Los Angeles, California
• LAC & USC Medical Center — Los Angeles, California
• University of Califorina, Los Angeles (UCLA) — Los Angeles, California
• Valley Childrens Hospital — Madera, California
• Sharp Memorial Hospital — San Diego, California
• St. Francis Medical Center — Colorado Springs, Colorado
• Connecticut Children'S Medical Center - Uconn - School of Medicine — Hartford, Connecticut
• University of Florida Health — Gainesville, Florida
• Wolfson Children'S Hospital — Jacksonville, Florida
• Uf Health Jacksonville — Jacksonville, Florida
• University of Miami/Holtz Children'S Hospital — Miami, Florida
• Sheridan Clinical Research / Plantation General Hospital — Plantation, Florida
• University of South Florida — Tampa, Florida
• St. Joseph'S Women'S Hospital — Tampa, Florida
• Georgia Regents University — Augusta, Georgia
• Children'S Hospital of the University of Illinois — Chicago, Illinois
• North Shore University Health System — Evanston, Illinois
• SIU School of Medicine - HSHS St. John's Children's Hospital — Springfield, Illinois
• Memorial Hospital of South Bend — South Bend, Indiana
• Wesley Medical Center — Wichita, Kansas
• Tufts Children's Hospital — Boston, Massachusetts

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Necrotizing Enterocolitis

• Early Predictors of Necrotizing Enterocolitis in Neonates — Columbus, Ohio
• RIC-NEC Randomized Controlled Trial — Cincinnati, Ohio
• A Cohort Study of the Intestinal Microbiota of Premature Infants — Sacramento, California
• WithHolding Enteral Feeds Around Blood Transfusion (International) — Halifax, Nova Scotia
• Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) — Little Rock, Arkansas

Explore by condition: All Necrotizing Enterocolitis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.